Massachusetts General Hospital:企業のM&A・事業提携・投資動向

◆英語タイトル:Massachusetts General Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1965
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:172
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Massachusetts General Hospital – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Massachusetts General Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Massachusetts General Hospital since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Massachusetts General Hospital’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Massachusetts General Hospital. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Massachusetts General Hospital’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Massachusetts General Hospital and its subsidiaries since 2007.
- Information about key financial and legal advisors for Massachusetts General Hospital’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Massachusetts General Hospital’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Overview 7
Mergers and Acquisitions – Deal reports 8
PARTNERSHIP 9
Partnership – Overview 9
Partnership – Deal reports 10
APPENDIX 162
Contact Us 162
About MarketLine Financial Deals Database 162
Deal Definition and Methodology 164
About MarketLine 171

List of Tables
Table 1: Massachusetts General Hospital M&A volume and value trend (2014-YTD2018)
Table 2: Massachusetts General Hospital M&A activity by geography (2014-YTD2018)
Table 3: Massachusetts General Hospital partnership volume and value trend (2014-YTD2018)
Table 4: Massachusetts General Hospital partnership trend by key deal type (2014-YTD2018)

List of Figures
Figure 1: Massachusetts General Hospital M&A volume and value trend (2014-YTD2018)
Figure 2: Massachusetts General Hospital M&A activity by geography (2014-YTD2018)
Figure 3: Massachusetts General Hospital partnership volume and value trend (2014-YTD2018)
Figure 4: Massachusetts General Hospital partnership trend by key deal type (2014-YTD2018)

★海外企業調査レポート[Massachusetts General Hospital:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SomaLogic Inc:企業の製品パイプライン分析
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Universal Music Group:企業の戦略的SWOT分析
    Universal Music Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kia Motors Corporation:企業の戦略・SWOT・財務情報
    Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ideaya Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ideaya Biosciences Inc (Ideaya Biosciences) is a biotechnology company that focuses to discover and develop personalized synthetic lethality medicines and immuno-oncology therapies. The company offers medicines targeting the DNA damage and repair; and immuno-oncology therapies targeting the …
  • Shanghai Kinetic Medical Co Ltd (300326):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Kinetic Medical Co Ltd (KMC) is a medical device company. The company’s product categories include orthopaedics, ENT products, and vascular surgery products. Its orthopaedic products comprise wire anchor, cervical anterior nail plate system, vertebral dilatation ballon catheter, bon …
  • Allied International Corporation:企業の戦略・SWOT・財務情報
    Allied International Corporation - Strategy, SWOT and Corporate Finance Report Summary Allied International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • LKQ Corporation:企業のM&A・事業提携・投資動向
    LKQ Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LKQ Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Qatari Diar Real Estate Investment Co:企業のM&A・事業提携・投資動向
    Qatari Diar Real Estate Investment Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Qatari Diar Real Estate Investment Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • One Lambda Inc:医療機器:M&Aディール及び事業提携情報
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device manufacturing company that offers laboratory products. The company develops and distributes antibody detection products and histocompatibility typing tests. Its products include HLA testing reagents …
  • Epax Norway AS:戦略・SWOT・企業財務分析
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • TriMas Corporation:企業のM&A・事業提携・投資動向
    TriMas Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TriMas Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Safe Orthopaedics SA (SAFOR):企業の製品パイプライン分析2018
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • GamaMabs Pharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GamaMabs Pharma SA (GamaMabs) is a clinical-stage immuno-oncology company that develops optimized therapeutic antibodies for the treatment of cancer. The company’s lead product candidate GM102, is an anti-AMHR2, Emabling engineered humanized mAb product targeting the receptor of anti-Mulleri …
  • Spectris Plc (SXS):企業の財務・戦略的SWOT分析
    Spectris Plc (SXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Praxair Inc (PX)-石油・ガス分野:企業M&A・提携分析
    Summary Praxair Inc (Praxair) is a producer and supplier of industrial gases. The company offers atmospheric gases including oxygen, nitrogen, argon and rare gases, and process gases such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene. It also designs and builds …
  • Harbin Pharmaceutical Group Co Ltd (600664):企業の財務・戦略的SWOT分析
    Harbin Pharmaceutical Group Co Ltd (600664) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Energy XXI Gulf Coast Inc (EGC):石油・ガス:M&Aディール及び事業提携情報
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • AyoxxA Biosystems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary AyoxxA Biosystems GmbH (AyoxxA) is a life science tools company that provides protein analysis solutions. The company offers multiple detection kits, cytokine detection kits, human inflammation kits, mouse inflammation kits, and human opthalmology kits. Its services include complete testing …
  • Nanyang Technological University:企業の戦略的SWOT分析
    Nanyang Technological University - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • The Pep BoysManny, Moe & Jack:企業の戦略・SWOT・財務分析
    The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report Summary The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆